Integrated Software Solution for Analytical Development in the Biopharmaceutical Industry
Learn how integration and automation can be used to improve consistency, data integrity, scalability in this case study focusing on how an analytical development lab achieved this using connected software.
In this webinar, you will learn:
- How to identify and address common pain points in disconnected lab environments (data silos, manual transfers, and inconsistent reporting)
- How connected software integrates instrument control, data acquisition, and analysis into one centralized workflow
- Practical approaches for ensuring data integrity, regulatory approvals, and advancing toward the connected “lab of the future” (including advanced technologies from Thermo Fisher Scientific)
In this educational session, Da Ren of BioTherapeutics Solutions LLC, will share a case study on deploying a fully integrated software environment in the lab.
You’ll see how connected software solutions streamling workflows (in this case, analytical development) by centralizing instrument monitoring, data acquisition, and analysis. This helps teams reduce costs, improve scalability, and maintain compliance.
Analytical development in biologics and pharmaceuticals often struggles with familiar bottlenecks: maintaining data integrity, meeting regulatory requirements, scaling processes, and maintaining consistency across teams. Traditional lab setups, where instruments and data systems operate in isolation, make these challenges even harder to overcome.
We’ll also discuss how integrated platforms align with emerging expectations for the “lab of the future”, from supporting regulatory approvals to improving training and reproducibility using analytical chemistry applications as examples.
Join us to learn practical strategies you can apply in your own workflows, and see how connected labs are shaping the future of biologics development.
Presenter: Da Ren (Founder and CEO, BioTherapeutics Solutions LLC)
Dr. Da Ren, founder of BioTherapeutics Solutions (BTS), is a trailblazer in the field of Quality Control with his development of the Multi-Attribute Method (MAM). This innovative approach has not only optimized efficiency but also ensured product quality, earning acceptance from over 30 regulatory agencies worldwide. Beyond his pioneering work, Dr. Ren actively contributes to the industry by serving on advisory boards and participating in organizations such as the MAM Consortium. He holds a Ph.D. in Analytical Chemistry from the University of Akron and has held influential roles at both Amgen and Waters Corporation.
